跳至主要内容
临床试验/IRCT20230415057911N2
IRCT20230415057911N2已完成3 期

Comparison of the Safety and Efficacy of Lacosamide and Topiramate on Control of Neonatal Refractory Seizures

Iran University of Medical Sciences0 个研究点目标入组 54 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 day 至 3 months(—)
性别
All

入选标准

  • Neonates with seizure who did not respond to phenobarbital (dose40 mg/kg) and Levebel (40 mg/kg).
  • Infants under 3 months with refractory seizures whose seizures have started since infancy (under one month).
  • Seizures due to secondary abnormalities in asphyxia, brain structural disorders, familial seizures, congenital and acquired infections, vascular lesions

排除标准

  • Seizures that started after neonatal Period
  • Seizures due to secondary abnormalities in metabolic disorders or electrolyte disorders.

研究者

相似试验